NEW YORK (GenomeWeb News) – A UK insurance industry group has decided to extend a rule through the year 2014 that keeps insurance customers from having to disclose genetic information from predictive tests.
 
The Association of British Insurers agreed on June 13 to extend a moratorium that was initiated in 2001 on insurance companies requiring results from customers.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.